Characteristics of patients in MCL3 compared with MCL2
| Variable . | MCL3 . | MCL2 . | P . |
|---|---|---|---|
| Male sex (%) | 129 (80) | 113 (71) | .05 |
| Median age (range), y | 58 (28-65) | 56 (32-65) | |
| Stage IV (%) | 139 (88) | 136 (85) | .37 |
| MIPI score (%) | |||
| Low | 77 (48) | 80 (51) | .75 |
| Intermediate | 49 (31) | 41 (26) | |
| High | 33 (21) | 37 (23) | |
| Cytologic variant (%) | |||
| Blastoid | 28 (18) | 31 (19) | .36 |
| Common | 128 (82) | 129 (81) | |
| % Ki67 (%) | |||
| 0-9 | 11 (9) | 10 (8) | .94 |
| 10-29 | 61 (49) | 60 (50) | |
| >29 | 53 (42) | 50 (42) |
| Variable . | MCL3 . | MCL2 . | P . |
|---|---|---|---|
| Male sex (%) | 129 (80) | 113 (71) | .05 |
| Median age (range), y | 58 (28-65) | 56 (32-65) | |
| Stage IV (%) | 139 (88) | 136 (85) | .37 |
| MIPI score (%) | |||
| Low | 77 (48) | 80 (51) | .75 |
| Intermediate | 49 (31) | 41 (26) | |
| High | 33 (21) | 37 (23) | |
| Cytologic variant (%) | |||
| Blastoid | 28 (18) | 31 (19) | .36 |
| Common | 128 (82) | 129 (81) | |
| % Ki67 (%) | |||
| 0-9 | 11 (9) | 10 (8) | .94 |
| 10-29 | 61 (49) | 60 (50) | |
| >29 | 53 (42) | 50 (42) |